Economic impact of tropical diseases
Economic impact of tropical diseases
Explanation
upd
8/18/24
Precisely
Simpler
Shorter
Main
Neglected tropical diseases (NTDs) are a diverse group of communicable diseases that prevail in tropical and subtropical conditions and disproportionately affect the world's poorest people. NTDs lead to significant economic burden through:
Direct costs: Expenses incurred due to NTDs, including costs of diagnosis, treatment, and transportation to health facilities.
Indirect costs: Economic losses resulting from reduced work productivity, lower educational attainment, and lost income due to NTD-related disability or premature death.
Out-of-pocket expenditure: Payments made directly by individuals to healthcare providers for services not covered by insurance, which can lead to catastrophic health expenditure and impoverishment.
Societal costs: Long-term consequences like stigma, social exclusion, and reduced quality of life that hinder economic development in affected regions.
The direct and indirect costs of NTDs are estimated at $35.9 billion globally each year. Individuals in Africa alone could have averted over $342 billion in health expenditure and lost productivity from 2015-2030 if NTDs were eliminated.
Terms
Neglected tropical diseases (NTDs): A diverse group of communicable diseases that prevail in tropical and subtropical conditions and affect over 1 billion people globally. Examples include dengue fever, malaria, Zika virus, chikungunya fever, leprosy, lymphatic filariasis, schistosomiasis, and onchocerciasis.
Direct costs: Expenses incurred due to NTDs, including costs of diagnosis, treatment, and transportation to health facilities.
Indirect costs: Economic losses resulting from reduced work productivity, lower educational attainment, and lost income due to NTD-related disability or premature death.
Out-of-pocket expenditure: Payments made directly by individuals to healthcare providers for services not covered by insurance.
Analogy
The economic impact of NTDs is like a hidden tax on the poor. Just as a tax siphons money away, NTDs siphon the financial resources of affected individuals and communities. Over time, this "NTD tax" keeps families trapped in a cycle of poverty and holds back the economic development of entire regions, much like how high taxes can stifle economic growth.
Misconception
Many people believe that the costs of NTDs are primarily borne by the health sector. In reality, NTDs place a tremendous economic burden on households, communities and countries beyond just healthcare expenditures. Lost productivity and income due to NTD-related disability and early death have far-reaching economic consequences. Additionally, many assume that public health insurance schemes cover NTD treatment costs. However, gaps in coverage often force patients to pay out-of-pocket, creating financial barriers to care.
History
Pre-2000s: Limited recognition of the collective economic burden of NTDs
Early 2000s: Initial studies began quantifying the economic costs and productivity losses associated with specific NTDs
Late 2000s: Researchers started estimating the global economic impact of NTDs, finding annual losses in the billions of dollars
2010s: Increased focus on the cost-effectiveness of NTD interventions and their potential return on investment for economic development
2020s: Growing recognition of the links between NTDs, poverty, and the economic benefits of tackling them alongside other development efforts
How to use it
Health economists can conduct studies on the direct and indirect costs of NTDs in different settings to build the investment case for NTD control and encourage domestic financing.
Policymakers can use estimates of productivity losses and economic burden to advocate for including NTD services in universal health coverage and social protection schemes.
Business leaders can factor in the economic impact of NTDs when making decisions about investing in endemic countries and consider supporting NTD programs as part of corporate social responsibility efforts.
Facts
The direct and indirect costs of NTDs are estimated at $35.9 billion globally each year.
NTDs are estimated to cause $4.2 billion in lost productivity annually in Africa alone.
Individuals in Africa could have averted over $342 billion in health expenditure and lost productivity from 2015-2030 if NTDs were eliminated.
Every $1 invested in NTD control is estimated to yield $25-$30 in economic benefits.
Achieving the WHO NTD 2030 targets could avert over $1 trillion in economic losses between 2021-2030.
Main
Neglected tropical diseases (NTDs) are a diverse group of communicable diseases that prevail in tropical and subtropical conditions and disproportionately affect the world's poorest people. NTDs lead to significant economic burden through:
Direct costs: Expenses incurred due to NTDs, including costs of diagnosis, treatment, and transportation to health facilities.
Indirect costs: Economic losses resulting from reduced work productivity, lower educational attainment, and lost income due to NTD-related disability or premature death.
Out-of-pocket expenditure: Payments made directly by individuals to healthcare providers for services not covered by insurance, which can lead to catastrophic health expenditure and impoverishment.
Societal costs: Long-term consequences like stigma, social exclusion, and reduced quality of life that hinder economic development in affected regions.
The direct and indirect costs of NTDs are estimated at $35.9 billion globally each year. Individuals in Africa alone could have averted over $342 billion in health expenditure and lost productivity from 2015-2030 if NTDs were eliminated.
Terms
Neglected tropical diseases (NTDs): A diverse group of communicable diseases that prevail in tropical and subtropical conditions and affect over 1 billion people globally. Examples include dengue fever, malaria, Zika virus, chikungunya fever, leprosy, lymphatic filariasis, schistosomiasis, and onchocerciasis.
Direct costs: Expenses incurred due to NTDs, including costs of diagnosis, treatment, and transportation to health facilities.
Indirect costs: Economic losses resulting from reduced work productivity, lower educational attainment, and lost income due to NTD-related disability or premature death.
Out-of-pocket expenditure: Payments made directly by individuals to healthcare providers for services not covered by insurance.
Analogy
The economic impact of NTDs is like a hidden tax on the poor. Just as a tax siphons money away, NTDs siphon the financial resources of affected individuals and communities. Over time, this "NTD tax" keeps families trapped in a cycle of poverty and holds back the economic development of entire regions, much like how high taxes can stifle economic growth.
Misconception
Many people believe that the costs of NTDs are primarily borne by the health sector. In reality, NTDs place a tremendous economic burden on households, communities and countries beyond just healthcare expenditures. Lost productivity and income due to NTD-related disability and early death have far-reaching economic consequences. Additionally, many assume that public health insurance schemes cover NTD treatment costs. However, gaps in coverage often force patients to pay out-of-pocket, creating financial barriers to care.
History
Pre-2000s: Limited recognition of the collective economic burden of NTDs
Early 2000s: Initial studies began quantifying the economic costs and productivity losses associated with specific NTDs
Late 2000s: Researchers started estimating the global economic impact of NTDs, finding annual losses in the billions of dollars
2010s: Increased focus on the cost-effectiveness of NTD interventions and their potential return on investment for economic development
2020s: Growing recognition of the links between NTDs, poverty, and the economic benefits of tackling them alongside other development efforts
How to use it
Health economists can conduct studies on the direct and indirect costs of NTDs in different settings to build the investment case for NTD control and encourage domestic financing.
Policymakers can use estimates of productivity losses and economic burden to advocate for including NTD services in universal health coverage and social protection schemes.
Business leaders can factor in the economic impact of NTDs when making decisions about investing in endemic countries and consider supporting NTD programs as part of corporate social responsibility efforts.
Facts
The direct and indirect costs of NTDs are estimated at $35.9 billion globally each year.
NTDs are estimated to cause $4.2 billion in lost productivity annually in Africa alone.
Individuals in Africa could have averted over $342 billion in health expenditure and lost productivity from 2015-2030 if NTDs were eliminated.
Every $1 invested in NTD control is estimated to yield $25-$30 in economic benefits.
Achieving the WHO NTD 2030 targets could avert over $1 trillion in economic losses between 2021-2030.
Main
Neglected tropical diseases (NTDs) are a diverse group of communicable diseases that prevail in tropical and subtropical conditions and disproportionately affect the world's poorest people. NTDs lead to significant economic burden through:
Direct costs: Expenses incurred due to NTDs, including costs of diagnosis, treatment, and transportation to health facilities.
Indirect costs: Economic losses resulting from reduced work productivity, lower educational attainment, and lost income due to NTD-related disability or premature death.
Out-of-pocket expenditure: Payments made directly by individuals to healthcare providers for services not covered by insurance, which can lead to catastrophic health expenditure and impoverishment.
Societal costs: Long-term consequences like stigma, social exclusion, and reduced quality of life that hinder economic development in affected regions.
The direct and indirect costs of NTDs are estimated at $35.9 billion globally each year. Individuals in Africa alone could have averted over $342 billion in health expenditure and lost productivity from 2015-2030 if NTDs were eliminated.
Terms
Neglected tropical diseases (NTDs): A diverse group of communicable diseases that prevail in tropical and subtropical conditions and affect over 1 billion people globally. Examples include dengue fever, malaria, Zika virus, chikungunya fever, leprosy, lymphatic filariasis, schistosomiasis, and onchocerciasis.
Direct costs: Expenses incurred due to NTDs, including costs of diagnosis, treatment, and transportation to health facilities.
Indirect costs: Economic losses resulting from reduced work productivity, lower educational attainment, and lost income due to NTD-related disability or premature death.
Out-of-pocket expenditure: Payments made directly by individuals to healthcare providers for services not covered by insurance.
Analogy
The economic impact of NTDs is like a hidden tax on the poor. Just as a tax siphons money away, NTDs siphon the financial resources of affected individuals and communities. Over time, this "NTD tax" keeps families trapped in a cycle of poverty and holds back the economic development of entire regions, much like how high taxes can stifle economic growth.
Misconception
Many people believe that the costs of NTDs are primarily borne by the health sector. In reality, NTDs place a tremendous economic burden on households, communities and countries beyond just healthcare expenditures. Lost productivity and income due to NTD-related disability and early death have far-reaching economic consequences. Additionally, many assume that public health insurance schemes cover NTD treatment costs. However, gaps in coverage often force patients to pay out-of-pocket, creating financial barriers to care.
History
Pre-2000s: Limited recognition of the collective economic burden of NTDs
Early 2000s: Initial studies began quantifying the economic costs and productivity losses associated with specific NTDs
Late 2000s: Researchers started estimating the global economic impact of NTDs, finding annual losses in the billions of dollars
2010s: Increased focus on the cost-effectiveness of NTD interventions and their potential return on investment for economic development
2020s: Growing recognition of the links between NTDs, poverty, and the economic benefits of tackling them alongside other development efforts
How to use it
Health economists can conduct studies on the direct and indirect costs of NTDs in different settings to build the investment case for NTD control and encourage domestic financing.
Policymakers can use estimates of productivity losses and economic burden to advocate for including NTD services in universal health coverage and social protection schemes.
Business leaders can factor in the economic impact of NTDs when making decisions about investing in endemic countries and consider supporting NTD programs as part of corporate social responsibility efforts.
Facts
The direct and indirect costs of NTDs are estimated at $35.9 billion globally each year.
NTDs are estimated to cause $4.2 billion in lost productivity annually in Africa alone.
Individuals in Africa could have averted over $342 billion in health expenditure and lost productivity from 2015-2030 if NTDs were eliminated.
Every $1 invested in NTD control is estimated to yield $25-$30 in economic benefits.
Achieving the WHO NTD 2030 targets could avert over $1 trillion in economic losses between 2021-2030.
Materials for self-study
+ Suggest a material
Register to Use the Bookmarking Feature
By registering, you can:
Save materials for later (bookmarks)
Track your progress on roadmaps and blocks
Access selected medium and full roadmaps for free
Get notified about new roadmaps
Register to Use the Bookmarking Feature
By registering, you can:
Save materials for later (bookmarks)
Track your progress on roadmaps and blocks
Access selected medium and full roadmaps for free
Get notified about new roadmaps
Register to Use the Bookmarking Feature
By registering, you can:
Save materials for later (bookmarks)
Track your progress on roadmaps and blocks
Access selected medium and full roadmaps for free
Get notified about new roadmaps
Check exercise
You're a health economist working in a tropical country where neglected tropical diseases (NTDs) are prevalent. The government is considering cutting funding for NTD control programs, arguing that they're too expensive. How would you make a case for continued investment in NTD control based on its economic impact?
Register to Track Your Progress
By registering, you can:
Save materials for later (bookmarks)
Track your progress on roadmaps and blocks
Access selected medium and full roadmaps for free
Get notified about new roadmaps
Register to Track Your Progress
By registering, you can:
Save materials for later (bookmarks)
Track your progress on roadmaps and blocks
Access selected medium and full roadmaps for free
Get notified about new roadmaps
Register to Track Your Progress
By registering, you can:
Save materials for later (bookmarks)
Track your progress on roadmaps and blocks
Access selected medium and full roadmaps for free
Get notified about new roadmaps
Updates
Subscribe to Use Updates Feature
By subscribing, you can:
Access all roadmaps
Access updates for blocks and roadmaps
Get feedback to your answers for exercises
Consult with experts for guidance
Order a custom block or roadmap monthly
Conversation with premium AI
Subscribe to Use Updates Feature
By subscribing, you can:
Access all roadmaps
Access updates for blocks and roadmaps
Get feedback to your answers for exercises
Consult with experts for guidance
Order a custom block or roadmap monthly
Conversation with premium AI
Subscribe to Use Updates Feature
By subscribing, you can:
Access all roadmaps
Access updates for blocks and roadmaps
Get feedback to your answers for exercises
Consult with experts for guidance
Order a custom block or roadmap monthly
Conversation with premium AI
Roadmaps where it's used
Related blocks
Share